BACKGROUND: There are concerns about the effects of in utero exposure to antiretroviral drugs (ARVs) on the development of HIV-exposed but uninfected (HEU) children. The aim of this study was to evaluate whether in utero exposure to ARVs is associated with lower birth weight/height and reduced growth during the first 2 years of life. METHODS: This cohort study was conducted among HEU infants born between 1996 and 2010 in Tertiary children's hospital in Rio de Janeiro, Brazil. Weight was measured by mechanical scale, and height was measured by measuring board. Z-scores for weight-for-age (WAZ), length-for-age (LAZ) and weight-for-length were calculated. We modeled trajectories by mixed-effects models and adjusted for mother's age, CD4 cell count, viral load, year of birth and family income. RESULTS: A total of 588 HEU infants were included of whom 155 (26%) were not exposed to ARVs, 114 (19%) were exposed early (first trimester) and 319 (54%) later. WAZ were lower among infants exposed early compared with infants exposed later: adjusted differences were -0.52 (95% confidence interval [CI]: -0.99 to -0.04, P = 0.02) at birth and -0.22 (95% CI: -0.47 to 0.04, P = 0.10) during follow-up. LAZ were lower during follow-up: -0.35 (95% CI: -0.63 to -0.08, P = 0.01). There were no differences in weight-for-length scores. Z-scores of infants exposed late during pregnancy were similar to unexposed infants. CONCLUSIONS: In HEU children, early exposure to ARVs was associated with lower WAZ at birth and lower LAZ up to 2 years of life. Growth of HEU children needs to be monitored closely.
BACKGROUND: There are concerns about the effects of in utero exposure to antiretroviral drugs (ARVs) on the development of HIV-exposed but uninfected (HEU) children. The aim of this study was to evaluate whether in utero exposure to ARVs is associated with lower birth weight/height and reduced growth during the first 2 years of life. METHODS: This cohort study was conducted among HEU infants born between 1996 and 2010 in Tertiary children's hospital in Rio de Janeiro, Brazil. Weight was measured by mechanical scale, and height was measured by measuring board. Z-scores for weight-for-age (WAZ), length-for-age (LAZ) and weight-for-length were calculated. We modeled trajectories by mixed-effects models and adjusted for mother's age, CD4 cell count, viral load, year of birth and family income. RESULTS: A total of 588 HEU infants were included of whom 155 (26%) were not exposed to ARVs, 114 (19%) were exposed early (first trimester) and 319 (54%) later. WAZ were lower among infants exposed early compared with infants exposed later: adjusted differences were -0.52 (95% confidence interval [CI]: -0.99 to -0.04, P = 0.02) at birth and -0.22 (95% CI: -0.47 to 0.04, P = 0.10) during follow-up. LAZ were lower during follow-up: -0.35 (95% CI: -0.63 to -0.08, P = 0.01). There were no differences in weight-for-length scores. Z-scores of infants exposed late during pregnancy were similar to unexposed infants. CONCLUSIONS: In HEU children, early exposure to ARVs was associated with lower WAZ at birth and lower LAZ up to 2 years of life. Growth of HEU children needs to be monitored closely.
Authors: Edgardo G Szyld; Eduardo M Warley; Laura Freimanis; René Gonin; Pedro E Cahn; Guilherme A Calvet; Geraldo Duarte; Victor H Melo; Jennifer S Read Journal: AIDS Date: 2006-11-28 Impact factor: 4.177
Authors: Amira Al-Uzri; Matthew Matheson; Debbie S Gipson; Susan R Mendley; Stephen R Hooper; Ora Yadin; David J Rozansky; Marva Moxey-Mims; Susan L Furth; Bradley A Warady; Arlene C Gerson Journal: J Pediatr Date: 2013-04-26 Impact factor: 4.406
Authors: Carla E Ransom; Yanling Huo; Kunjal Patel; Gwendolyn B Scott; Heather D Watts; Paige Williams; George K Siberry; Elizabeth G Livingston Journal: J Acquir Immune Defic Syndr Date: 2013-12-01 Impact factor: 3.731
Authors: Lesley Fairley; Emily S Petherick; Laura D Howe; Kate Tilling; Noel Cameron; Debbie A Lawlor; Jane West; John Wright Journal: Arch Dis Child Date: 2013-02-16 Impact factor: 3.791
Authors: Malango T Msukwa; Janne Estill; Andreas D Haas; Joep J van Oosterhout; Lyson Tenthani; Mary-Ann Davies; Kali Tal; Nozgechi Phiri; Adrian Spoerri; Bryan C Mthiko; Frank Chimbwandira; Olivia Keiser Journal: AIDS Date: 2018-09-24 Impact factor: 4.177
Authors: Anna Mageras; Ellen Brazier; Théodore Niyongabo; Gad Murenzi; Jean D'Amour Sinayobye; Adebola A Adedimeji; Christella Twizere; Elizabeth A Kelvin; Kathryn Anastos; Denis Nash; Heidi E Jones Journal: Int J STD AIDS Date: 2021-02-03 Impact factor: 1.359
Authors: Amy L Slogrove; Renaud Becquet; Ellen G Chadwick; Hélène C F Côté; Shaffiq Essajee; Rohan Hazra; Valériane Leroy; Mary Mahy; Maurine Murenga; Jacqueline Wambui Mwangi; Laura Oyiengo; Nigel Rollins; Martina Penazzato; George R Seage; Lena Serghides; Marissa Vicari; Kathleen M Powis Journal: Front Pediatr Date: 2018-05-30 Impact factor: 3.418